Skip to content
Merito
← Back to results
EB-2 NIWBiotech and pharmaEmployerDecided March 2026Dismissed

Outcome: Dismissed

MAR212026_01B5203

Merit and national importanceNot metWell positionedNot reached / not discussedBalance favors a waiverNot reached / not discussed

Our summary

A senior scientist with doctoral degree in biology at a multinational pharmaceutical company sought NIW for EB-2. The AAO dismissed appeal after finding proposed drug design research endeavor lacks national importance. Published work and connection to broad health initiatives insufficient; specific endeavor impact not demonstrated at national scale.

Official PDF

Official PDF ↗

Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.

No criterion in the table was found met in this decision.

What was missing

  • Merit and national importance · Individual research contributions do not establish national importance; field importance distinct from particular endeavor impact

Criteria

CriterionReadingWhy
Merit and national importanceNot metIndividual research contributions do not establish national importance; field importance distinct from particular endeavor impact
Well positionedNot reached / not discussedNot reached; first prong failure dispositive
Balance favors a waiverNot reached / not discussedNot reached; first prong failure dispositive

A published decision describes one case. It is not legal advice and not a prediction for yours.

Similar decisions

Decisions whose text is closest to this one.